Merkel Cell Carcinoma
Merkel Cell Carcinoma
Association with Jakafi
Jakafi (ruxolitinib) is an oral medication used to treat myelofibrosis and polycythemia vera. Its mechanism of action is to block JAK1 and JAK2 kinases involved in immune-related biochemical
Read more
Media included
Price:
$399
Buy now
Or partners log in and checkout with
Merkel Cell Carcinoma
Merkel Cell Carcinoma
Association with Jakafi
Research Guides
Price
0.25 engagement credits
Order now
Complete the form below to access the Merkel Cell Carcinoma document in Expert IQ
Unlock unlimited access to every litigation research document
With a subscription to our Research Guide Library, you can access all the medico-legal research you need at significantly reduced rates.
Subscribe and save
Your information will not be shared. View our privacy policy.